Ortho-Clinical Diagnostics
This article was originally published in The Gray Sheet
Executive Summary
J&J unit gains non-exclusive license enabling development of NT-proBNP cardiac marker-based immunoassays to detect congestive heart failure under a pact with Roche Diagnostics. The test would run on J&J's Vitros ECiQ immunodiagnostic system...